GERN Market Cap History



Below is a table of the GERN market cap history going back to 2/23/2010:

Date GERN Market Cap
2/23/2010557.45M
4/26/2010570.43M
7/26/2010520.85M
10/25/2010606.29M
2/22/2011628.45M
4/25/2011642.38M
7/25/2011540.16M
10/24/2011306.33M
2/22/2012259.68M
4/30/2012221.90M
7/30/2012231.01M
10/29/2012169.98M
3/1/2013188.03M
4/29/2013152.60M
8/1/2013171.10M
11/1/2013508.13M
3/6/2014717.03M
4/25/2014298.18M
8/4/2014387.50M
10/31/2014350.58M
3/6/2015551.95M
4/30/2015572.28M
7/31/2015640.48M
10/30/2015549.03M
3/3/2016448.15M
4/29/2016468.93M
7/29/2016426.49M
10/28/2016311.92M
2/21/2017350.15M
5/1/2017410.67M
8/2/2017343.90M
10/25/2017328.02M
3/7/2018430.55M
5/3/2018640.40M
7/24/2018615.13M
10/25/2018290.70M
3/1/2019285.18M
4/29/2019350.65M
7/26/2019227.99M
7/30/2019292.57M
11/1/2019293.67M
3/2/2020232.40M
7/31/2020493.64M
11/2/2020543.33M
3/1/2021592.46M
5/4/2021436.44M
8/11/2021400.75M
11/4/2021534.44M
3/1/2022346.39M
5/3/2022547.30M
9/30/2022892.09M
3/9/20231.36B
5/5/20231.40B
7/27/20231.58B
10/31/20231.03B
2/23/20241.07B
4/26/20242.25B
8/5/20242.72B
11/4/20242.57B

Also see: GERN Shares Outstanding History
and GERN YTD Return
GERN Historical Market Cap:
+10.95% CAGR
GERN Historical Market Cap: +10.95% CAGR

Mouse over chart for data details
2/23/2010 ...11/4/2024
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. Co. is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. We show 59 historical shares outstanding datapoints in our GERN shares outstanding history coverage, used to compute GERN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing GERN market cap history over the course of time is important for investors interested in comparing GERN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of GERN versus a peer is one thing; comparing GERN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like GERN can fluctuate over the course of history. With this page we aim to empower investors researching GERN by allowing them to research the GERN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree GERN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Geron (GERN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

GFOR Market Cap History
GH Market Cap History
GHDX Market Cap History
GILD Market Cap History
GKOS Market Cap History
GLSI Market Cap History
GLTO Market Cap History
GLUE Market Cap History
GLYC Market Cap History
GMED Market Cap History
More Healthcare companies »

 

GERN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2025, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.